Overview

Safety and Efficacy Study of Autologous Engineered Skin Substitute to Treat Partial- and Full-Thickness Burn Wounds

Status:
Unknown status

Trial end date:
2020-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to test how well the investigational treatment, Engineered Skin Substitutes (ESS-W), works for covering and treating burn wounds. The areas of the body that are treated with ESS-W will be compared to similar areas treated with the patient's own skin (split-thickness skin autograft (AG)). A skin autograft (AG) will be performed by taking healthy skin from one area of the body and placing it on the burned area.

Phase:

Phase 2

Details

Lead Sponsor:

Amarantus BioScience Holdings, Inc.

Collaborator:

Amarex Clinical Research